File: /home/govancoz/mail/.spam/new/1699961858.M888882P3684115.zacp120.ve.host,S=8587,W=8742
Return-Path: <jimmy@baka-community.de>
Delivered-To: govancoz+spam@zacp120.ve.host
Received: from zacp120.ve.host
by zacp120.ve.host with LMTP
id UGuhNAJcU2UTNzgAvcbEzQ
(envelope-from <jimmy@baka-community.de>)
for <govancoz+spam@zacp120.ve.host>; Tue, 14 Nov 2023 13:37:38 +0200
Return-path: <jimmy@baka-community.de>
Envelope-to: CANDICE@GOVAN.CO.ZA
Delivery-date: Tue, 14 Nov 2023 13:37:38 +0200
Received: from lvps92-51-133-96.dedicated.hosteurope.de ([92.51.133.96]:53071 helo=92-51-133-96.dedicated.hosteurope.de)
by zacp120.ve.host with esmtps (TLS1.3) tls TLS_AES_256_GCM_SHA384
(Exim 4.96.2)
(envelope-from <jimmy@baka-community.de>)
id 1r2rjc-00FjOm-2o
for CANDICE@GOVAN.CO.ZA;
Tue, 14 Nov 2023 13:37:38 +0200
Received: from [107.150.38.202] (unknown [107.150.38.202])
by 92-51-133-96.dedicated.hosteurope.de (Postfix) with ESMTPA id 2E4942A26D;
Tue, 14 Nov 2023 03:48:24 +0000 (UTC)
Content-Type: multipart/alternative; boundary="===============1369028047=="
MIME-Version: 1.0
To: Recipients <jimmy@baka-community.de>
From: "Dr. Yasunobu Otsuga" <jimmy@baka-community.de>
Date: Mon, 13 Nov 2023 21:48:12 -0600
Reply-To: dr.otsuga@gmail.com
X-Spam-Status: Yes, score=11.5
X-Spam-Score: 115
X-Spam-Bar: +++++++++++
X-Spam-Report: Spam detection software, running on the system "zacp120.ve.host",
has identified this incoming email as possible spam. The original
message has been attached to this so you can view it or label
similar future email. If you have any questions, see
root\@localhost for details.
Content preview: Hello Daito Pharma Co., Ltd. is a Japan-based manufacturing
pharmaceutical company engaged in the pharmaceutical ingredients and formulation
business . Are you interested in working with us to be our [...]
Content analysis details: (11.5 points, 5.0 required)
pts rule name description
---- ---------------------- --------------------------------------------------
0.5 SUBJ_ALL_CAPS Subject is all capitals
0.0 HTML_MESSAGE BODY: HTML included in message
2.0 PYZOR_CHECK Listed in Pyzor
(https://pyzor.readthedocs.io/en/latest/)
0.0 KAM_DMARC_STATUS Test Rule for DKIM or SPF Failure with Strict
Alignment
3.9 HELO_DYNAMIC_IPADDR2 Relay HELO'd using suspicious hostname (IP
addr 2)
-0.0 T_SCC_BODY_TEXT_LINE No description available.
1.0 KAM_LAZY_DOMAIN_SECURITY Sending domain does not have any
anti-forgery methods
1.6 FSL_BULK_SIG Bulk signature with no Unsubscribe
2.5 FREEMAIL_FORGED_REPLYTO Freemail in Reply-To, but not From
X-Spam-Flag: YES
Subject: ***SPAM*** ABOUT PARTNERSHIP WITH DAITO PHARMA.
You will not see this in a MIME-aware mail reader.
--===============1369028047==
Content-Type: text/plain; charset="iso-8859-1"
MIME-Version: 1.0
Content-Transfer-Encoding: quoted-printable
Content-Description: Mail message body
Hello =
Daito Pharma Co., Ltd. is a Japan-based manufacturing pharmaceutical comp=
any engaged in the pharmaceutical ingredients and formulation business . Ar=
e you interested in working with us to be our company representative in you=
r country, The Republic of South Africa, for a period of five years contrac=
t? Please Kindly let us know if you are interested while I direct you to m=
y working company email address =
Apologies for using my personal email address for these proposals. However=
, The reason was to get an immediate notification from you once you respond=
ed. =
Best regards,
Dr. Yasunobu Otsuga President & CEO Daito Pharmaceutical Co., Ltd. 326 Yoka=
machi, Toyama City, Toyama Prefecture 939-8567
--===============1369028047==
Content-Type: text/html; charset="iso-8859-1"
MIME-Version: 1.0
Content-Transfer-Encoding: quoted-printable
Content-Description: Mail message body
<HTML><head><meta http-equiv=3D"Content-Type" content=3D"text/html; charset=
=3Diso-8859-1"/></head><BODY><DIV style=3D"FONT-SIZE: small; FONT-FAMILY: A=
rial, Helvetica, sans-serif; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-T=
RANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(34,34,34); FONT-STYLE: normal;=
ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-vari=
ant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width=
: 0px; text-decoration-thickness: initial; text-decoration-style: initial; =
text-decoration-color: initial">
<DIV style=3D"FONT-SIZE: small; FONT-FAMILY: Arial, Helvetica, sans-serif; =
WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: =
400; COLOR: rgb(34,34,34); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTE=
R-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-v=
ariant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickn=
ess: initial; text-decoration-style: initial; text-decoration-color: initia=
l">Hello</DIV>
<DIV style=3D"FONT-SIZE: small; FONT-FAMILY: Arial, Helvetica, sans-serif; =
WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: =
400; COLOR: rgb(34,34,34); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTE=
R-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-v=
ariant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickn=
ess: initial; text-decoration-style: initial; text-decoration-color: initia=
l"><BR></DIV>
<DIV style=3D"FONT-SIZE: small; FONT-FAMILY: Arial, Helvetica, sans-serif; =
WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: =
400; COLOR: rgb(34,34,34); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTE=
R-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-v=
ariant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickn=
ess: initial; text-decoration-style: initial; text-decoration-color: initia=
l">Daito Pharma Co., Ltd. is a Japan-based manufacturing pharmaceutic=
al company engaged in the pharmaceutical ingredients and formulation busine=
ss . Are you interested in working with us to be our company representative=
in your country, The Republic of South Africa, for a period of five years =
contract? Please Kindly let us know if you are interested while I dir=
ect you to my working company email address</DIV>
<DIV style=3D"FONT-SIZE: small; FONT-FAMILY: Arial, Helvetica, sans-serif; =
WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: =
400; COLOR: rgb(34,34,34); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTE=
R-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-v=
ariant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickn=
ess: initial; text-decoration-style: initial; text-decoration-color: initia=
l">
<DIV><BR></DIV>
<DIV>Apologies for using my personal email address for these proposals. How=
ever, The reason was to get an immediate notification from you once you res=
ponded.</DIV></DIV>
<DIV style=3D"FONT-SIZE: small; FONT-FAMILY: Arial, Helvetica, sans-serif; =
WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: =
400; COLOR: rgb(34,34,34); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTE=
R-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-v=
ariant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickn=
ess: initial; text-decoration-style: initial; text-decoration-color: initia=
l"><BR></DIV>
<DIV style=3D"FONT-SIZE: small; FONT-FAMILY: Arial, Helvetica, sans-serif; =
WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: =
400; COLOR: rgb(34,34,34); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTE=
R-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-v=
ariant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickn=
ess: initial; text-decoration-style: initial; text-decoration-color: initia=
l">
<DIV><SPAN style=3D"FONT-SIZE: 11pt; FONT-FAMILY: Gulim, ??, sans-serif; CO=
LOR: rgb(0,0,0)">Best regards,</SPAN><BR style=3D"FONT-SIZE: 14px; FO=
NT-FAMILY: Gulim, ??, sans-serif; COLOR: rgb(0,0,0)"><SPAN style=3D"FONT-SI=
ZE: 11pt"><SPAN style=3D"FONT-FAMILY: Gulim, ??, sans-serif; COLOR: rgb(0,0=
,0)">Dr. </SPAN></SPAN>Yasunobu Otsuga</DIV>
<DIV><SPAN style=3D"FONT-SIZE: 11pt; FONT-FAMILY: Gulim, ??, sans-serif; CO=
LOR: rgb(0,0,0)">President & CEO</SPAN></DIV>
<DIV>Daito Pharmaceutical Co., Ltd.</DIV>
<DIV>326 Yokamachi, Toyama City, Toyama Prefecture 939-8567</DIV></DIV></DI=
V></BODY></HTML>
--===============1369028047==--